Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Healthcare Reform

 

Hirslanden hospital closure looms as tariff and Canton reforms bite

Mediclinic-owned Swiss hospital group Hirslanden looks set to close a 28-bed hospital unless "alternative proposals" can be found, blaming tariff changes and moves by the local Canton. It is less than 1% of Hirslanden's sales but is the first casualty of the tariff reforms amongst the hospital market's big players. We talk to the CEOs of both Mediclinic International and Hirslanden about the closure and the Swiss market generally.

Interview: Julia Khalimova, Healthcare Quality and Patient Safety Specialist, International Finance Corporation (IFC)

A recent study in the Lancet showed that it was more dangerous to have access to poor quality health care than to have no access to health care. That is particularly true in Emerging Markets where quality varies dramatically. Julia Khalimova, Healthcare Quality and Patient Safety Specialist at IFC, the arm of the World Bank that invests in the private sectors of emerging markets, has been studying the field for ten years and IFC has recently launched a tool to enable operators to measure and improve. We talk to her about the problem. What progress has been made? And what is the best solution?

PE sniffing around Aleris

Investor is to complete its pullout from the health care services sector according to sources. Having flogged Aleris' primary care arm to and its care business to Ambea, we hear it now wants to sell off its hospital business in Sweden, Denmark and Norway.

Does Value Health have a future?

Value health is the revolutionary idea pioneered by Harvard guru Michael Porter. He had the temerity to suggest providers should be rewarded for quality, rather than activity and that the patient should be viewed and consulted as customers. Invented in the early noughties, it hit a high water mark 7-8 years ago when Obamacare was rolled out incorporating the concept. Then it felt like an inexorable river.

DACH: Opportunities and pitfalls

A robust DACH session at HBI 2019 reached broad agreement over the most - and least - favourable areas for investment in healthcare in the region, but struggled to agree on the likely implication of the key legislation about to be brought in.

Can pan-Nordic synergies really exist?

Three of the Nordic's largest operators took to the stage at HBI 2019 to speak about pan-Nordic collaboration. Here's what Fredrik Gren, CEO of Ambea, Alexander Wennergren Helm, CEO of Aleris, and Yrjö Närnhinen, CEO of Terveystalo, said.

Find Us